Khrysos Industries, Inc. Reveals State of the Art, Florida Based Hemp Processing and Manufacturing Facility

82,000 Square Foot, GMP Qualified Facility will be New Home for Khrysos’ Centralized Post Processing and Finished Goods Manufacturing.


Khrysos Industries, Inc. a wholly owned subsidiary of Youngevity International, Inc.​ (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise announced today that it has leased 82,000 square feet in Orlando, Florida to house its post processing hemp derived products and finished goods manufacturing facility. The single use building was the former home of Nephron Pharmaceuticals GMP Certified sterile manufacturing operations. The state-of-the-art facility features a 46,200 sq. ft. production area that includes 5,200 sq. ft. of class C7 sterile capable workspace, power is provided via a redundant utility system for continuous operation with 5000 amp of 480v 3 phase power available throughout the facility. Additionally, the facility contains a high purity reverse osmosis water system, 10,000 sq. ft. of air-conditioned warehouse space, a 1,500 sq. ft secure vault for storing high dollar finished goods and ingredients, and a complete SCADA monitoring system.

Read the full Press Release.